Israeli drug delivery company PolyPid has partnered with U.S.-based devicemaker MIS Implants Technologies to develop a dual polymer-lipid bone-healing technology specifically for dental use. PolyPid's line of BonyPid nanodelivery platforms, recently tested in clinical trials, allows for the sustained release of drugs when pumped into damaged bones--the dental adaptation would help treat conditions such as periodontitis, an inflammatory tooth disease, with a controlled therapeutic release. Combined with MIS's specially designed implants, the companies expect to launch the technology by early 2015. Release